Metabolic therapeutics therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Familial Chylomicronemia (Type I Hyperlipoproteinemia) (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... (Type I Hyperlipoproteinemia) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Familial Chylomicronemia (Type I Hyperlipoproteinemia), complete with analysis by Stage of Developm......" | 30-Apr-2021 | $2000 | |
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... rcholesterolemia (Type II Hyperlipoproteinemia) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia), complete with analy......" | 30-Apr-2021 | $2000 | |
Diabetic Neuropathic Foot Ulcers (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... report provides comprehensive information on the therapeutics under development for Diabetic Neuropathic Foot Ulcers, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule ......" | 30-Apr-2021 | $2000 | |
Growth Hormone Deficiency (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... rehensive information on the therapeutics under development for Growth Hormone Deficiency, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers......" | 30-Apr-2021 | $2000 | |
Hyperlipidemia (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... apeutics under development for Hyperlipidemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of t......" | 30-Apr-2021 | $2000 | |
Lipid Disorders (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... herapeutics under development for Lipid Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action ......" | 30-Apr-2021 | $2000 | |
Lipodystrophy (Lipoatrophy) (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... s comprehensive information on the therapeutics under development for Lipodystrophy (Lipoatrophy), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report als......" | 30-Apr-2021 | $2000 | |
Lysosomal Storage Disorder (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... omprehensive information on the therapeutics under development for Lysosomal Storage Disorder, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also co......" | 30-Apr-2021 | $2000 | |
Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... on the therapeutics under development for Metabolic Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacolog......" | 30-Apr-2021 | $2000 | |
Familial Amyloid Cardiomyopathy (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... port provides comprehensive information on the therapeutics under development for Familial Amyloid Cardiomyopathy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type......" | 30-Apr-2021 | $2000 | |
|